The Department of Labor (DOL) issued regulations in the last year of the Trump administration imposing new transparency requirements for group health plans. These changes mean that employers will need to take action to ensure they are prepared to comply with the new obligations.
Price comparison tool must provide cost-sharing information for 500 items and services as of the first day of the plan year beginning in 2023.
Plan Years of Beginning in 2024
Price comparison tool must provide cost-sharing information for all covered items and services as of the first day of the plan year beginning in 2024.
One obligation (effective in July 2022) was to post information on publicly available websites detailing cost information about their group health plan.
The other requirement for plan years beginning in 2023 is that group health plans and health insurance issuers make an internet-based price comparison tool available to participants, beneficiaries, and enrollees. This tool aims to provide consumers with real-time estimates of their cost-sharing liability from different providers for covered items and services, including prescription drugs, so they can shop and compare prices before receiving care. Upon request, plans and issuers must also provide this information on paper or over the telephone.
For plan years beginning on or after Jan. 1, 2023, plans and issuers must make price comparison information available for 500 shoppable items, services, and drugs on the first day of the plan year. For plan years beginning on or after Jan. 1, 2024, price comparison information must be available for all covered items, services, and drugs as of the first day of the plan year. More information, including the list of 500 items and services, is available through the Centers for Medicare & Medicaid Services (CMS).
Most employers will rely on their issuers or third-party administrators (TPAs) to develop and maintain the price comparison tool and provide related disclosures on paper or over the phone upon request.
Most employers will rely on their issuers or TPAs to provide the price comparison tool.
This Alert is not intended to be exhaustive, nor should any discussion or opinions be construed as legal advice. Readers should contact legal counsel for legal advice.